Deletion of crry and DAF on murine platelets stimulates thrombopoiesis and increases factor H-dependent resistance of peripheral platelets to complement attack

Journal of Immunology

Volumn 190, Issue 6, 2013, Pages 2886-2895

  Barata, Lidia ^a   Miwa, Takashi ^a   Sato, Sayaka ^a   Kim, David ^a   Mohammed, Imran ^a   Song, Wen Chao ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FACTOR H; COMPLEMENT RECEPTOR; COMPLEMENT RECEPTOR 1 RELATED PROTEIN Y; DECAY ACCELERATING FACTOR; THROMBOCYTE FACTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELL SURVIVAL; CHIMERA; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; CONTROLLED STUDY; FEMALE; GENE DELETION; IMMUNOREGULATION; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; THROMBOCYTE COUNT; THROMBOCYTE METABOLISM; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

ANIMALS; ANTIGENS, CD55; BLOOD PLATELETS; CELL SURVIVAL; COMPLEMENT C3; COMPLEMENT FACTOR H; COMPLEMENT PATHWAY, ALTERNATIVE; DOWN-REGULATION; HUMANS; MEGAKARYOCYTES; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, ANIMAL; PROTEIN BINDING; RANDOM ALLOCATION; RECEPTORS, COMPLEMENT; THROMBOPOIESIS; UP-REGULATION;

EID: 84874852792     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202536     Document Type: Article

References (39)

1. Dunkelberger, J. R., and W.-C. Song. 2010. Complement and its role in innate and adaptive immune responses. Cell Res. 20: 34-50.
2. Walport, M. J. 2001. Complement. First of two parts. N. Engl. J. Med. 344: 1058-1066.
3. Thurman, J. M., and V. M. Holers. 2006. The central role of the alternative complement pathway in human disease. J. Immunol. 176: 1305-1310.
4. Miwa, T., and W. C. Song. 2001. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases. Int. Immunopharmacol. 1: 445-459.
5. Kim, D. D., and W.-C. Song. 2006. Membrane complement regulatory proteins. Clin. Immunol. 118: 127-136.
6. Jó zsi, M., and P. F. Zipfel. 2008. Factor H family proteins and human diseases. Trends Immunol. 29: 380-387.
7. Tsujimura, A., K. Shida, M. Kitamura, M. Nomura, J. Takeda, H. Tanaka, M. Matsumoto, K. Matsumiya, A. Okuyama, Y. Nishimune, et al. 1998. Molecular cloning of a murine homologue of membrane cofactor protein (CD46): preferential expression in testicular germ cells. Biochem. J. 330: 163-168.
8. Miwa, T., M. Nonaka, N. Okada, S. Wakana, T. Shiroishi, and H. Okada. 1998. Molecular cloning of rat and mouse membrane cofactor protein (MCP, CD46): preferential expression in testis and close linkage between the mouse Mcp and Cr2 genes on distal chromosome 1. Immunogenetics 48: 363-371.
9. Molina, H. 2002. The murine complement regulator Crry: new insights into the immunobiology of complement regulation. Cell. Mol. Life Sci. 59: 220-229.
10. Holers, V. M., T. Kinoshita, and H. Molina. 1992. The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function. Immunol. Today 13: 231-236.
11. Rodríguez de Córdoba, S., J. Esparza-Gordillo, E. Goicoechea de Jorge, M. Lopez-Trascasa, and P. Sánchez-Corral. 2004. The human complement factor H: functional roles, genetic variations and disease associations. Mol. Immunol. 41: 355-367.
12. Rosse, W. F., and C. J. Parker. 1985. Paroxysmal nocturnal haemoglobinuria. Clin. Haematol. 14: 105-125.
13. Frémeaux-Bacchi, V., E. C. Miller, M. K. Liszewski, L. Strain, J. Blouin, A. L. Brown, N. Moghal, B. S. Kaplan, R. A. Weiss, K. Lhotta, et al 2008. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 112: 4948-4952.
14. Goicoechea de Jorge, E., C. L. Harris, J. Esparza-Gordillo, L. Carreras, E. A. Arranz, C. A. Garrido, M. López-Trascasa, P. Sánchez-Corral, B. P. Morgan, and S. Rodríguez de Córdoba. 2007. Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proc. Natl. Acad. Sci. USA 104: 240-245.
15. Brown, J. H., T. J. Wilson, V. Mackie, I. J. Scully, M. Tredger, M. M. Moore, I. Mc, N. I. Dougall, L. Strain, K. J. Marchbank, et al. 2012. Postpartum aHUS secondary to a genetic abnormality in factor H acquired through liver transplantation. Am. J. Transplant. 12: 1632-1636.
16. Xu, C., D. Mao, V. M. Holers, B. Palanca, A. M. Cheng, and H. Molina. 2000. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 287: 498-501.
17. Sun, X., C. D. Funk, C. Deng, A. Sahu, J. D. Lambris, andW. C. Song. 1999. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting. Proc. Natl. Acad. Sci. USA 96: 628-633.
18. Miwa, T., L. Zhou, B. Hilliard, H. Molina, and W. C. Song. 2002. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack. Blood 99: 3707-3716.
19. Molina, H., T. Miwa, L. Zhou, B. Hilliard, D. Mastellos, M. A. Maldonado, J. D. Lambris, and W. C. Song. 2002. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Blood 100: 4544-4549.
20. Kim, D. D., T. Miwa, and W.-C. Song. 2006. Retrovirus-mediated overexpression of decay-accelerating factor rescues Crry-deficient erythrocytes from acute alternative pathway complement attack. J. Immunol. 177: 5558-5566.
21. Kim, D. D., T. Miwa, Y. Kimura, R. A. Schwendener, M. van Lookeren Campagne, and W. C. Song. 2008. Deficiency of decay-accelerating factor and complement receptor 1-related gene/protein y on murine platelets leads to complement-dependent clearance by the macrophage phagocytic receptor CRIg. Blood 112: 1109-1119.
22. Miwa, T., L. Zhou, Y. Kimura, D. Kim, A. Bhandoola, and W. C. Song. 2009. Complement-dependent T-cell lymphopenia caused by thymocyte deletion of the membrane complement regulator Crry. Blood 113: 2684-2694.
23. Zhang, X., Y. Kimura, C. Fang, L. Zhou, G. Sfyroera, J. D. Lambris, R. A. Wetsel, T. Miwa, and W. C. Song. 2007. Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 110: 228-236.
24. Lesher, A. M., L. Zhou, Y. Kimura, S. Sato, D. Gullipalli, A. P. Herbert, P. N. Barlow, H. U. Eberhardt, C. Skerka, P. F. Zipfel, et al. 2013. Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis. J. Am. Soc. Nephrol. 24: 53-65.
25. Kisanuki, Y. Y., R. E. Hammer, J. Miyazaki, S. C. Williams, J. A. Richardson, and M. Yanagisawa. 2001. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 230: 230-242.
26. Kühn, S., and P. F. Zipfel. 1995. The baculovirus expression vector pBSV-8His directs secretion of histidine-tagged proteins. Gene 162: 225-229.
27. Kimura, Y., T. Miwa, L. Zhou, and W.-C. Song. 2008. Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement. Blood 111: 732-740.
28. Hu, Z., W. B. Slayton, L. M. Rimsza, M. Bailey, H. Sallmon, and M. C. Sola- Visner. 2010. Differences between newborn and adult mice in their response to immune thrombocytopenia. Neonatology 98: 100-108.
29. Gitler, A. D., Y. Kong, J. K. Choi, Y. Zhu, W. S. Pear, and J. A. Epstein. 2004. Tie2-Cre-induced inactivation of a conditional mutant Nf1 allele in mouse results in a myeloproliferative disorder that models juvenile myelomonocytic leukemia. Pediatr. Res. 55: 581-584.
30. de Lange, W. J., C. M. Halabi, A. M. Beyer, and C. D. Sigmund. 2008. Germ line activation of the Tie2 and SMMHC promoters causes noncell-specific deletion of floxed alleles. Physiol. Genomics 35: 1-4.
31. Tiedt, R., T. Schomber, H. Hao-Shen, and R. C. Skoda. 2007. Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo. Blood 109: 1503-1506.
32. Ferreira, V. P., A. P. Herbert, H. G. Hocking, P. N. Barlow, and M. K. Pangburn. 2006. Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces. J. Immunol. 177: 6308-6316.
33. Bao, L., Y. Wang, A. Chang, A. W. Minto, J. Zhou, H. Kang, M. Haas, and R. J. Quigg. 2007. Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure. J. Am. Soc. Nephrol. 18: 811-822.
34. Wu, X., D. Spitzer, D. Mao, S. L. Peng, H. Molina, and J. P. Atkinson. 2008. Membrane protein Crry maintains homeostasis of the complement system. J. Immunol. 181: 2732-2740.
35. Ruseva, M. M., T. R. Hughes, R. M. Donev, B. Sivasankar, M. C. Pickering, X. Wu, C. L. Harris, and B. P. Morgan. 2009. Crry deficiency in complement sufficient mice: C3 consumption occurs without associated renal injury. Mol. Immunol. 46: 803-811.
36. Miwa, T., L. Zhou, R. Tudoran, J. D. Lambris, M. P. Madaio, M. Nangaku, H. Molina, and W. C. Song. 2007. DAF/Crry double deficiency in mice exacerbates nephrotoxic serum-induced proteinuria despite markedly reduced systemic complement activity. Mol. Immunol. 44: 139-146.
37. Pickering, M. C., H. T. Cook, J.Warren, A. E. Bygrave, J. Moss, M. J.Walport, and M. Botto. 2002. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat. Genet. 31: 424-428.
38. Kajander, T., M. J. Lehtinen, S. Hyvarinen, A. Bhattacharjee, E. Leung, D. E. Isenman, S. Meri, A. Goldman, and T. S. Jokiranta. 2011. Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement. Proc. Natl. Acad. Sci. USA 108: 2897-2902.
39. Cheng, Z.-Z., J. Hellwage, H. Seeberger, P. F. Zipfel, S. Meri, and T. S. Jokiranta. 2006. Comparison of surface recognition and C3b binding properties of mouse and human complement factor H. Mol. Immunol. 43: 972-979.